Ketotifen Stulln 0,25 Mg/Ml

Ketotifen, the active ingredient in Ketotifen Stulln 0.25 mg/mL, is an antihistamine presented as a 0.25 mg/mL eye‑drop solution for ocular use. It reduces histamine‑mediated inflammation and itching in the eyes, providing relief for patients with allergic conjunctivitis and other allergy‑related ocular symptoms.

GNH USA supplies Ketotifen Stulln 0.25 mg/mL as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU quality standards and is manufactured under strict GMP conditions.

Ketotifen is used to manage ocular allergy conditions by blocking histamine pathways. - Allergic conjunctivitis: reduces redness, swelling and itching of the conjunctiva. - Seasonal allergic eye disease: alleviates symptoms during pollen or allergen exposure. - Ocular itching due to allergy: provides rapid relief of itching and discomfort.

Ketotifen eye drops may cause local or systemic adverse reactions, although most are mild.

Common Side Effects: - Burning sensation in the eye. - Stinging upon instillation. - Temporary blurred vision. - Redness of the eye.

Serious or Rare Side Effects: - Anaphylactic reaction. - Persistent eye pain. - Corneal ulcer. - Significant swelling of the eyelids.

When using Ketotifen eye drops, consider the following precautions. - Avoid use in patients with known hypersensitivity to ketotifen or any excipients: discontinue immediately if a reaction occurs. - Do not use if the eye‑drop container is damaged or the solution is discolored: check integrity before use. - Limit use in patients with severe ocular infections: consult an ophthalmologist. - Caution in pregnant or breastfeeding women: safety not established, use only if benefit outweighs risk. - Store at room temperature (≤25 °C): keep in the original container, protect from light and moisture.

Ketotifen may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent use of other ocular antihistamines: may increase risk of local irritation. - Systemic antihistamines or mast‑cell stabilizers: additive pharmacologic effect, monitor for excessive sedation if systemic absorption occurs. - Contact lenses: may trap solution and cause discomfort; remove lenses before administration.

Moderate Interactions (Monitor Closely): - Topical ocular steroids: may mask signs of infection, monitor ocular health. - Non‑steroidal anti‑inflammatory eye drops: potential additive irritation, observe for increased redness. - Systemic medications that prolong QT interval: although rare with topical use, monitor cardiac status in high‑risk patients.